Pharmacogenetics of sulfonylurea: Presence of CYP2C92, CYP2C93 and a novel allele, CYP2C961, in Type 2 diabetes patients under sulfonylurea therapy

CYP2C9 is an important member of the cytochrome P450 gene family involved in the metabolism of 15% of the drugs including an oral antidiabetic agent sulfonylurea. This study aims to investigate the frequency of CYP2C9*2 and CYP2C9*3 alleles of the gene in the sulfonylurea treated diabetic subjects i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pakistan journal of pharmaceutical sciences 2020-07, Vol.33 (4(Supplementary)), p.1771-1777
Hauptverfasser:	Muhammad, Sumaira Deen, Khan, Hazar, Hussain, Mushtaq, Zeb, Tehseen Fatima, Kumar, Darshan, Rahi, Rahimullah, Asif, Mahayrookh, Balooch, Akhter Ali
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!